Kal Çakmaklıoğulları Elçin, Özkan Sevencan Nurhayat
Department of Medical Microbiology, Karabuk University Training and Research Hospital,Karabuk,Turkey.
Department of Internal Medicine, Karabuk University Training and Research Hospital, Karabuk, Turkey.
J Infect Dev Ctries. 2019 Jul 31;13(7):665-670. doi: 10.3855/jidc.11285.
The aim of this study was to investigate the prevalence of Adenovirus-36 (Ad-36) in overweight and obese patients and the effects of this virus on some metabolic parameters.
The study included 236 female patients with body mass index (BMI) ≥ 25. The patients were separated into 2 groups as overweight (BMI: 25-29.99) and obese (BMI ≥ 30). To quantitatively determine the antibody (Ab) specific to adenovirus type 36 in the serum samples, the enzyme-immunoassay (EIA) method was used (AdV36-Ab, ELISA Kit, MyBioSource). Laboratoryparameters were compared between patients who are Ad-36 Ab positive and negative.
Of the total 236 patients, 82 (34.7%) were determined as Ad-36 positive and 154 (65.3%) were negative. Ad-36 Ab positivity was statistically significantly higher in the obese group (p = 0.018). The HOMA-IR index, triglyceride, total cholesterol, high-density lipoprotein, and low-density lipoprotein were found to be the same in both groups with no statistically significant differences(p > 0.05). Vitamin D levels were significantly higher in BMI ≥ 30 Ad-36 Ab positive group than negative group (p < 0.05).
The frequency ofAd-36 Ab positivity was significantly higher in the obese group than in the overweight group. These results can be considered to shed a different perspective from previous reports in literature as only overweight and obese females were included. To the best of our knowledge, this study is the first to have shown that Ad-36 has the effect of elevating the Vitamin D levels.
本研究旨在调查36型腺病毒(Ad-36)在超重和肥胖患者中的流行情况以及该病毒对某些代谢参数的影响。
该研究纳入了236名体重指数(BMI)≥25的女性患者。患者被分为超重(BMI:25-29.99)和肥胖(BMI≥30)两组。为了定量测定血清样本中针对36型腺病毒的抗体(Ab),采用了酶免疫测定(EIA)方法(AdV36-Ab,ELISA试剂盒,MyBioSource)。对Ad-36抗体阳性和阴性的患者的实验室参数进行了比较。
在总共236名患者中,82名(34.7%)被确定为Ad-36阳性,154名(65.3%)为阴性。肥胖组中Ad-36抗体阳性率在统计学上显著更高(p = 0.018)。两组的稳态模型评估胰岛素抵抗(HOMA-IR)指数、甘油三酯、总胆固醇、高密度脂蛋白和低密度脂蛋白水平相同,无统计学显著差异(p>0.05)。BMI≥30的Ad-36抗体阳性组的维生素D水平显著高于阴性组(p<0.05)。
肥胖组中Ad-36抗体阳性率显著高于超重组。由于仅纳入了超重和肥胖女性,这些结果可以被认为从文献中先前的报告提供了不同的视角。据我们所知,本研究首次表明Ad-36具有升高维生素D水平的作用。